The ExoProTher Medical Team
Lana Volokh, PhD
Co-founder & CEO
Dr. Lana Volokh has 18 years of experience in healthcare industry in variety of positions including R&D, system engineering, advanced technologies management, clinical research management, product, clinical and regulatory strategy development and management. She has worked in corporate (GE Healthcare, Israel and USA), academic (Johns Hopkins University) and start-up (Arineta, and more) environments. Dr. Volokh has been key contributor to development of a number of products combining high technology and clinical components.
(GE Healthcare Israel and USA, Johns Hopkins University)
Alex Tendler, PhD
Co-founder & CTO
Dr. Alex Tendler is an entrepreneur, scientist and researcher with vast experience in management of international projects in various areas of life sciences and biomedical engineering such as drug delivery, neuroscience and medical devices. He has extensive experience in leading multidisciplinary projects from concept development to clinical research, including IP development, scientific writing, and teaching. Dr. Tendler has deep knowledge of a wide range of research methods and techniques, including designing and monitoring laboratory and clinical trials and has led multiple innovative research and development teams. (Intel, Technion, University of Haifa, Rainbow Medical)
Mr. Shay Wail is a serial entrepreneur, Investor, advisor, and board member of start-ups in the tech and medical fields. Shay has extensive experience in early development of AR/VR/MR optical applications. Shay has large experience in strategic planning and business development, working for international corporations such as Apple, Intel and Broadcom as well as early stage start-ups.
Avi Treves PhD
Dr. Avi Treves is an expert in translational and clinical R&D, product development, one of pioneers of immuno-oncology and cell therapy, co-founder of several biotech companies, including NASDAQ traded Gamida-Cell. Dr. Treves was a member of The Israeli Ministry of Health Committee for Registering of Cellular Based Therapies. Previously served as Deputy Director of the Sheba Cancer Research Center and member of Ella Lemelbaum Institute for Tumor Immunology, Sheba Medical Center